Skip to main content

Innovation. Clarity. Execution.  I  Portfolio

Portfolio.

Life-changing innovation

The companies in which we have invested since the year 2006 have discovered and developed, fifteen approved medicines and products to the benefit of patients, physicians and our investors.

View and filter our portfolio below

Filter

Centessa

Centessa

Share sale
Acutus

Acutus

Cardiac mapping system for AF
Acutus

Acutus

IPO NASDAQ
Agenus

Agenus

Broad immunotherapy platform for cancer
ALETA

ALETA

Transformative adoptive cell therapy
Algeta

Algeta

Alpha-emitter anticancer agents
AlphaRose Therapeutics

AlphaRose Therapeutics

Revolutionizing Precision Medicine For Patients. By Patients.
Amphista

Amphista

Targeted Protein Degradation
Aravive

Aravive

Therapies targeting survival pathways for cancer
Argá Medtech

Argá Medtech

Next Generation Cardiac Ablation
Arrakis

Arrakis

Small molecule modulators of RNA
Artax

Artax

Novel therapy for autoimmune disease
Aura

Aura

Novel therapies for ocular cancers
AviadoBio

AviadoBio

Revolution in gene therapy for neurodegenerative disorders
Avila

Avila

Covalent small molecule platform
Axonics

Axonics

Novel sacral neuromodulation system
Beacon

Beacon

Transform lives with pioneering ocular gene therapy
Biocartis

Biocartis

Molecular diagnostics platform
CardiacAssist

CardiacAssist

Alpha-emitter anticancer agents
CardiAQ

CardiAQ

Novel device for mitral valve replacement
Cardiokine

Cardiokine

Cardio-renal drug development
Cellnovo

Cellnovo

Micro insulin pump with connectivity
Centessa

Centessa

Novel asset-centric pharmaceutical company
CN

CN

Nicotine replacement e-cigarette
Conatus

Conatus

Therapeutics for liver disease
Curve

Curve

Next-gen functional discovery platform
Eloxx

Eloxx

Ribosome Modulating Agents for Rare Disease
Emergent

Emergent

Innovative vaccines and therapeutics
Epitopea

Epitopea

Next generation immunotherapies
EUSA

EUSA

Trans-Atlantic specialty pharma company
F2G

F2G

Novel anti-fungal therapy
Glycomine

Glycomine

Developing Substrate Replacement Therapies
Highlight

Highlight

Bridging the innate to adaptive immune response
Infinity

Infinity

Chemical genomic-based drug discovery
Iterum

Iterum

Novel oral antibiotic
Kandy

Kandy

Therapeutics for Women’s Health
KuDos

KuDos

DNA damage repair therapy
Levicept

Levicept

Novel pain treatment for osteoarthritis
Micromet

Micromet

Bi-specific antibodies
MiroBio

MiroBio

Immune cell regulation
Moximed

Moximed

Novel device for treating osteoarthritis of the knee
Nalu

Nalu

Novel spinal cord stimulation device
NeRRe

NeRRe

Pipeline of neurokinin antagonists
Orphalan

Orphalan

Rare disease company
Pheno

Pheno

Remyelinating therapy development
PIC

PIC

Targeting oncogene translation
PowderMed

PowderMed

Needle-free vaccine delivery
Proximie

Proximie

Best-in-class technology for connected surgical care
Rappta

Rappta

Novel PP2A activators to treat cancer
Relief Cardiovascular

Relief Cardiovascular

Pioneering device for diuretic resistant heart failure
Respivert

Respivert

Novel therapies for respiratory disorders
Santarus

Santarus

Speciality pharmaceuticals
SEP

SEP

European pharma focused on urology
Thiakis

Thiakis

Novel hormone treatment for obesity
Tridek-One

Tridek-One

Novel approach for treatment of vasculitis
UniQure

UniQure

Gene therapy for rare disease
Ventus

Ventus

Innovative smoking cessation products

About

Leading Venture Investors
Learn More

Exit History

View Our Exit History
Learn More